EyePoint Pharmaceuticals Inc (EYPT)
8.63
+0.26
(+3.11%)
USD |
NASDAQ |
Oct 04, 16:00
8.65
+0.02
(+0.23%)
After-Hours: 20:00
EyePoint Pharmaceuticals Shareholders Equity (Annual): 266.32M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 266.32M |
December 31, 2022 | 96.37M |
December 31, 2021 | 184.38M |
December 31, 2020 | 18.54M |
December 31, 2019 | 8.33M |
December 31, 2018 | 37.63M |
June 30, 2018 | 11.69M |
June 30, 2017 | 13.34M |
June 30, 2016 | 20.88M |
June 30, 2015 | 23.37M |
June 30, 2014 | 14.92M |
June 30, 2013 | 7.70M |
Date | Value |
---|---|
June 30, 2012 | 13.64M |
June 30, 2011 | 37.43M |
June 30, 2010 | 33.04M |
June 30, 2009 | 23.54M |
June 30, 2008 | 30.08M |
June 30, 2007 | 83.55M |
June 30, 2006 | 129.96M |
June 30, 2005 | 60.52M |
June 30, 2004 | 25.60M |
June 30, 2003 | 4.095M |
June 30, 2001 | 4.573M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
8.33M
Minimum
2019
266.32M
Maximum
2023
114.79M
Average
96.37M
Median
2022
Shareholders Equity (Annual) Benchmarks
Cassava Sciences Inc | 137.47M |
Adverum Biotechnologies Inc | 83.47M |
Regenxbio Inc | 311.74M |
Editas Medicine Inc | 349.10M |
Apellis Pharmaceuticals Inc | 194.52M |